Simren Delaney
General Counsel at METAGENOMI, INC.
Net worth: 383 079 $ as of 2024-06-29
Network origin in Simren Delaney first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 17 | |
Wilson Sonsini Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati Miscellaneous Commercial ServicesCommercial Services Part of Wilson Sonsini Goodrich & Rosati PC, Wilson Sonsini Goodrich & Rosati is a leading provider of legal counsel for corporate and technology transactions, governance, intellectual property, disputes, and regulatory matters. The company is based in Hong Kong, Hong Kong. The Chinese company has 19 offices worldwide, including locations in technology and business hubs. Wilson Sonsini Goodrich & Rosati has been offering legal services for over 50 years, with a focus on serving the challenges faced by management and boards of directors of business enterprises. The company is nationally recognized for its expertise in corporate governance and finance, mergers and acquisitions, private equity, securities litigation, employment law, intellectual property, and antitrust, among other areas of law.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Simren Delaney via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director of Finance/CFO | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Analyst-Equity | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
CARIBOU BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Pennsylvania | College/University | Doctorate Degree | |
Kleiner Perkins Caufield & Byers LLC
Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Investment Managers | Private Equity Investor | |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Cameron Health, Inc.
Cameron Health, Inc. Medical SpecialtiesHealth Technology Cameron Health, Inc. develops medical devices for patients and medical professionals. It has developed a totally subcutaneous implantable defibrillator (S-ICD) system that remedies many of the issues associated with traditional implantable cardioverter defibrillators. The company was founded on August 21, 2000 and is headquartered in San Clemente, CA. | Medical Specialties | Director/Board Member | |
Texas A&M University | College/University | Graduate Degree | |
INSEAD | College/University | Masters Business Admin | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
University of Madras | College/University | Undergraduate Degree | |
University of Basel | College/University | Doctorate Degree | |
Anteis SA
Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Medical/Nursing Services | Director/Board Member | |
swiss smile Holding AG
swiss smile Holding AG Medical/Nursing ServicesHealth Services swiss smile Holding AG operates as a holding company with interests in operates a chain of dental clinics. It offers treatments in the areas of aesthetic dentistry, bleaching, implantology, orthodontic, oral surgery, endodontic, pediatric dentistry, periodontology, professional teeth cleaning, bad breath, prosthetic, tooth-colored filling, teeth grinding, general anesthetic, and emergency aspects. The firm also provides whitening toothpastes, herbal toothpastes, whitening toothbrushes, soft toothbrushes, waxed dental tapes, and interdental brushes. The company was founded by Haleh Abivardi Brönner and Golnar Abivardi Signer in 2006 and is headquartered in Zurich, Switzerland. | Medical/Nursing Services | Director/Board Member | |
Bellevue Asset Management (Venture Capital)
Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Investment Managers | Private Equity Investor | |
Columbia University Medical Center | College/University | Corporate Officer/Principal | |
Aleva Neurotherapeutics SA
Aleva Neurotherapeutics SA Electronic Equipment/InstrumentsElectronic Technology Aleva Neurotherapeutics SA develops next-generation implants for deep brain stimulation therapy. Its micro fabricated devices enable target specific stimulation and optimization of current therapies. The company was founded by Claudio Pollo, Jean-Pierre Rosat, Philipe Renaud, Paul Pyzowski and André Mercanzini and in August 2008 and is headquartered in Lausanne, Switzerland. | Electronic Equipment/Instruments | Director/Board Member | |
Informed Data Systems, Inc.
Informed Data Systems, Inc. Packaged SoftwareTechnology Services Informed Data Systems, Inc. is a biotechnology comapny, which engages in the provision of healthcare services. The company was founded by Jeffrey A. Dachis and is headquartered in New York, NY. | Packaged Software | Director/Board Member | |
eGenesis, Inc.
eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
9905553 Canada, Inc.
9905553 Canada, Inc. Internet Software/ServicesTechnology Services 9905553 Canada, Inc. operates as a digital market place that allows buyers and sellers to list, negotiate, and finalize grain deals. The company was founded by Brennan Turner and Alain Goubau and is headquartered in Ontario, Canada. | Internet Software/Services | Director/Board Member | |
Ada Health GmbH
Ada Health GmbH Internet Software/ServicesTechnology Services Ada Health GmbH offers a virtual assessment of health symptoms. It specializes in Personal Health, Artificial Intelligence, mHealth and Health Care services. The company was founded by Martin Hirsch, Daniel Nathrath and Claire Novorol and is headquartered in Berlin, Germany. | Internet Software/Services | Director/Board Member | |
Pairwise Plants Services
Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Pairwise Plants LLC operates as a agriculture company. The company was founded by Feng Zhang, David Liu and J. Keith Joung and is headquartered in Durham, NC. | Food: Major Diversified | Director/Board Member | |
Casebia Therapeutics LLP
Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
Joyn Bio LLC
Joyn Bio LLC Real Estate DevelopmentFinance Joyn Bio LLC is a joint venture between Leaps by Bayer and Ginkgo Bioworks that engineers microbes to improve naturally occurring processes in agriculture. The company is based in Boston, MA, and has two sites for leading scientists with diverse backgrounds. The company's focus is on developing probiotics for plants to provide growers with next-generation solutions to their biggest challenges. The company's first area of focus is on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture's reliance on nitrogen fertilizer and its environmental impact. | Real Estate Development | Director/Board Member | |
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Director/Board Member | |
TURNSTONE BIOLOGICS CORP. | Biotechnology | Director/Board Member | |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
CENTURY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Leaps by Bayer
Leaps by Bayer Investment ManagersFinance Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany. | Investment Managers | Private Equity Investor | |
PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member | |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky. | Biotechnology | Director/Board Member | |
Plant Response, Inc.
Plant Response, Inc. Agricultural Commodities/MillingProcess Industries Plant Response, Inc. is engaged in providing agricultural biological services. It offers cybelion, power coat, biohp, neptunion, biopath and PRB9 products. The company is headquartered in Durham, NC. | Agricultural Commodities/Milling | Director/Board Member | |
ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Diality, Inc.
Diality, Inc. Medical SpecialtiesHealth Technology Diality, Inc. is engaged in manufacturing medical devices. The company is headquartered in Irvine, CA. | Medical Specialties | Director of Finance/CFO | |
HAYA Therapeutics SA
HAYA Therapeutics SA BiotechnologyHealth Technology HAYA Therapeutics SA is a Swiss precision medicines company that focuses on developing programmable therapeutics targeting regulatory RNAs derived from the dark genome to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The company's discovery engine identifies novel targets and drug candidates with the potential for greater efficacy and safety than existing treatments. HAYA's lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting WISPER that is a heart-specific lncRNA known to be a fundamental regulator of pathological cardiac fibrosis in the context of heart failure. The company is headquartered at the Life Sciences Park Biopôle in Lausanne, CH, with laboratory facilities at JLABS @ San Diego. The company was founded by Samir Ounzain and Daniel Blessing, and Samir Ounzain has been the CEO since incorporation. | Biotechnology | Chairman |
Statistics
International
United States | 35 |
Switzerland | 7 |
Germany | 5 |
Canada | 4 |
France | 2 |
Sectoral
Health Technology | 22 |
Consumer Services | 9 |
Finance | 8 |
Commercial Services | 6 |
Health Services | 4 |
Operational
Director/Board Member | 85 |
Corporate Officer/Principal | 46 |
Chief Tech/Sci/R&D Officer | 18 |
Undergraduate Degree | 16 |
Doctorate Degree | 13 |
Most connected contacts
Insiders | |
---|---|
Jürgen Eckhardt | 34 |
Risa Stack | 26 |
Jak Knowles | 24 |
Sebastián Bernales | 19 |
Sarah Noonberg | 17 |
Willard Dere | 16 |
Santhosh Palani | 15 |
Jian Irish | 10 |
Pamela Wapnick | 9 |
Luis Borges | 9 |
Simon Harnest | 7 |
Justin Lang | 5 |
Brian Thomas | 5 |
Michael Conway | 5 |
Alan Brooks | 5 |
- Stock Market
- Insiders
- Simren Delaney
- Company connections